tiprankstipranks
Hinge Health, Inc. Class A (HNGE)
NYSE:HNGE
US Market
Want to see HNGE full AI Analyst Report?

Hinge Health, Inc. Class A (HNGE) Ratios

178 Followers

Hinge Health, Inc. Class A Ratios

HNGE's free cash flow for Q1 2026 was $0.85. For the 2026 fiscal year, HNGE's free cash flow was decreased by $ and operating cash flow was $0.18. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23
Liquidity Ratios
Current Ratio
1.22 1.47 2.34
Quick Ratio
1.19 1.43 2.30
Cash Ratio
0.45 0.57 1.21
Solvency Ratio
-1.21 -1.43 -0.02
Operating Cash Flow Ratio
0.51 0.47 0.20
Short-Term Operating Cash Flow Coverage
49.50 0.00 0.00
Net Current Asset Value
$ 88.34M$ 167.68M$ 326.89M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 0.01 0.02
Debt-to-Equity Ratio
0.02 0.02 0.03
Debt-to-Capital Ratio
0.02 0.02 0.03
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00
Financial Leverage Ratio
2.34 1.97 1.62
Debt Service Coverage Ratio
-122.81 0.00 0.00
Interest Coverage Ratio
0.00 0.00 0.00
Debt to Market Cap
<0.01 0.00 0.00
Interest Debt Per Share
0.09 0.10 0.14
Net Debt to EBITDA
0.35 0.37 54.60
Profitability Margins
Gross Profit Margin
80.80%79.65%77.00%
EBIT Margin
-80.91%-92.94%-2.88%
EBITDA Margin
-80.32%-92.07%-1.36%
Operating Profit Margin
-81.60%-92.94%-6.26%
Pretax Profit Margin
-78.82%-89.69%-2.88%
Net Profit Margin
-78.95%-89.86%-3.06%
Continuous Operations Profit Margin
-78.95%-89.86%-3.06%
Net Income Per EBT
100.16%100.19%106.01%
EBT Per EBIT
96.59%96.50%46.08%
Return on Assets (ROA)
-70.02%-70.93%-1.77%
Return on Equity (ROE)
-138.70%-139.55%-2.86%
Return on Capital Employed (ROCE)
-167.82%-142.90%-5.76%
Return on Invested Capital (ROIC)
-165.59%-141.34%-5.71%
Return on Tangible Assets
-77.04%-77.90%-1.96%
Earnings Yield
-11.78%-14.36%-0.41%
Efficiency Ratios
Receivables Turnover
5.62 8.90 9.19
Payables Turnover
1.79 0.00 0.00
Inventory Turnover
8.76 7.65 8.26
Fixed Asset Turnover
37.35 33.88 22.98
Asset Turnover
0.89 0.79 0.58
Working Capital Turnover Ratio
4.92 2.33 1.15
Cash Conversion Cycle
-97.75 88.72 83.92
Days of Sales Outstanding
64.90 41.02 39.73
Days of Inventory Outstanding
41.66 47.70 44.19
Days of Payables Outstanding
204.31 0.00 0.00
Operating Cycle
106.56 88.72 83.92
Cash Flow Ratios
Operating Cash Flow Per Share
2.67 2.16 0.63
Free Cash Flow Per Share
2.62 2.16 0.58
CapEx Per Share
0.04 <0.01 0.05
Free Cash Flow to Operating Cash Flow
0.98 1.00 0.92
Dividend Paid and CapEx Coverage Ratio
61.02 242.15 12.99
Capital Expenditure Coverage Ratio
61.02 242.15 12.99
Operating Cash Flow Coverage Ratio
30.08 21.33 4.43
Operating Cash Flow to Sales Ratio
0.32 0.29 0.13
Free Cash Flow Yield
4.83%4.64%1.54%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-8.49 -6.96 -245.56
Price-to-Sales (P/S) Ratio
6.60 6.26 7.51
Price-to-Book (P/B) Ratio
13.91 9.72 7.03
Price-to-Free Cash Flow (P/FCF) Ratio
20.69 21.54 64.79
Price-to-Operating Cash Flow Ratio
20.67 21.46 59.80
Price-to-Earnings Growth (PEG) Ratio
0.02 >-0.01 2.75
Price-to-Fair Value
13.91 9.72 7.03
Enterprise Value Multiple
-7.87 -6.43 -497.66
Enterprise Value
4.08B 3.48B 2.64B
EV to EBITDA
-7.87 -6.43 -497.66
EV to Sales
6.32 5.92 6.76
EV to Free Cash Flow
19.81 20.37 58.38
EV to Operating Cash Flow
19.48 20.29 53.89
Tangible Book Value Per Share
3.12 3.94 4.53
Shareholders’ Equity Per Share
3.96 4.78 5.34
Tax and Other Ratios
Effective Tax Rate
>-0.01 >-0.01 -0.06
Revenue Per Share
8.22 7.42 5.00
Net Income Per Share
-6.49 -6.67 -0.15
Tax Burden
1.00 1.00 1.06
Interest Burden
0.97 0.97 1.00
Research & Development to Revenue
0.58 0.63 0.25
SG&A to Revenue
1.04 1.10 0.58
Stock-Based Compensation to Revenue
0.96 1.09 <0.01
Income Quality
-0.41 -0.32 -4.11
Currency in USD